Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Texas professor, researcher elected 38th president of AAN
The American Academy of Neurology has elected Carlayne E. Jackson, MD, FAAN, a neurologist, researcher and professor of neurology and otolaryngology at the University of Texas Health Science Center at San Antonio, as its 38th president.
AHA: Screening needed to assess common cognitive impairment after stroke
Cognitive impairment is common among stroke survivors and cognition screenings should be part of a person’s multidisciplinary follow-up care, according to a new scientific statement from the American Heart Association.
Log in or Sign up for Free to view tailored content for your specialty!
Recent malpractice verdict highlights importance of asset protection planning
Among the various types of liability that physicians may face, including employee claims, HIPAA violations, cyber liability and slip-and-fall injuries, medical malpractice may be the most impactful.
FDA approves Qalsody for SOD-1 ALS
The FDA has approved Qalsody, an antisense oligonucleotide, to treat individuals with ALS associated with a mutation in the superoxide dismutase 1 gene.
VIDEO: First trimester exposure to dimethyl fumarate is safe
BOSTON — Women with MS who were exposed to dimethyl fumarate in the first trimester had no unexpected adverse pregnancy outcomes, according to Kerstin Hellwig, MD, in this Healio video from the American Academy of Neurology annual meeting.
Survey for health care workers: Have you ever encountered macro or microaggressions?
Physicians have created a survey for health care workers to assess experiences with microaggressions, sexism, racism and other forms of discrimination at work, school, in patient environments or during interactions with patients’ families.
Phase 2a clinical trial targeting anxiety, depression in Alzheimer’s begins
A biotech company has started the first clinical trial of a sublingual formulation targeting anxiety and depression in people with Alzheimer’s disease, according to a press release.
FDA grants fast track designation to exon-skipping Duchenne muscular dystrophy therapy
The FDA has granted fast track designation to AOC 1044 for the treatment of Duchenne muscular dystrophy in people with mutations amenable to exon 44 skipping, Avidity Biosciences announced in a press release.
Hunting for the ‘elusive’ Sjögren’s diagnosis: How multiple specialties can improve delays
In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.
VIDEO: No cognitive problems seen in pediatric MS
BOSTON — An evaluation of children with early-onset MS showed their cognitive performance was similar to healthy peers, Kimberly A. O’Neill, MD, said in this Healio video at the American Academy of Neurology annual meeting.
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read